These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 21054900

  • 1. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.
    Scott-Thomas AJ, Syhre M, Pattemore PK, Epton M, Laing R, Pearson J, Chambers ST.
    BMC Pulm Med; 2010 Nov 07; 10():56. PubMed ID: 21054900
    [Abstract] [Full Text] [Related]

  • 2. Potential sources of 2-aminoacetophenone to confound the Pseudomonas aeruginosa breath test, including analysis of a food challenge study.
    Scott-Thomas A, Pearson J, Chambers S.
    J Breath Res; 2011 Dec 07; 5(4):046002. PubMed ID: 21701048
    [Abstract] [Full Text] [Related]

  • 3. Electrochemistry provides a point-of-care approach for the marker indicative of Pseudomonas aeruginosa infection of cystic fibrosis patients.
    Metters JP, Kampouris DK, Banks CE.
    Analyst; 2014 Aug 21; 139(16):3999-4004. PubMed ID: 24926967
    [Abstract] [Full Text] [Related]

  • 4. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
    Davis TJ, Karanjia AV, Bhebhe CN, West SB, Richardson M, Bean HD.
    mSphere; 2020 Oct 07; 5(5):. PubMed ID: 33028687
    [Abstract] [Full Text] [Related]

  • 5. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis.
    Savelev SU, Perry JD, Bourke SJ, Jary H, Taylor R, Fisher AJ, Corris PA, Petrie M, De Soyza A.
    Lett Appl Microbiol; 2011 Jun 07; 52(6):610-3. PubMed ID: 21438899
    [Abstract] [Full Text] [Related]

  • 6. Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry.
    Shestivska V, Nemec A, Dřevínek P, Sovová K, Dryahina K, Spaněl P.
    Rapid Commun Mass Spectrom; 2011 Sep 15; 25(17):2459-67. PubMed ID: 21818806
    [Abstract] [Full Text] [Related]

  • 7. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
    Gilchrist FJ, Bright-Thomas RJ, Jones AM, Smith D, Spaněl P, Webb AK, Lenney W.
    J Breath Res; 2013 Jun 15; 7(2):026010. PubMed ID: 23680696
    [Abstract] [Full Text] [Related]

  • 8. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
    Kos R, Brinkman P, Neerincx AH, Paff T, Gerritsen MG, Lammers A, Kraneveld AD, Heijerman HGM, Janssens HM, Davies JC, Majoor CJ, Weersink EJ, Sterk PJ, Haarman EG, Bos LD, Maitland-van der Zee AH, Amsterdam Mucociliary Clearance Disease (AMCD) Research Group and the Amsterdam UMC Breath Research Group.
    J Cyst Fibros; 2022 Jan 15; 21(1):e28-e34. PubMed ID: 34016557
    [Abstract] [Full Text] [Related]

  • 9. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C, Hirsch T, Rösen-Wolff A, Kerkmann ML, Leupold W.
    Pediatr Pulmonol; 2003 Oct 15; 36(4):348-52. PubMed ID: 12950050
    [Abstract] [Full Text] [Related]

  • 10. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P, Sovová K, Dryahina K, Doušová T, Dřevínek P, Smith D.
    J Breath Res; 2016 Aug 17; 10(3):036013. PubMed ID: 27532768
    [Abstract] [Full Text] [Related]

  • 11. Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.
    Nasir M, Bean HD, Smolinska A, Rees CA, Zemanick ET, Hill JE.
    Sci Rep; 2018 Jan 16; 8(1):826. PubMed ID: 29339749
    [Abstract] [Full Text] [Related]

  • 12. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
    Pabary R, Huang J, Kumar S, Alton EW, Bush A, Hanna GB, Davies JC.
    Eur Respir J; 2016 Mar 16; 47(3):994-7. PubMed ID: 26846826
    [No Abstract] [Full Text] [Related]

  • 13. From molecules in space to molecules in breath.
    Smith D.
    Paediatr Respir Rev; 2016 Jan 16; 17():50-2. PubMed ID: 26541224
    [Abstract] [Full Text] [Related]

  • 14. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E, Segurado R, Jackson A, McClean S, Renwick J, Greally P.
    BMC Pulm Med; 2017 Apr 21; 17(1):70. PubMed ID: 28431569
    [Abstract] [Full Text] [Related]

  • 15. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
    Elborn JS, Cordon SM, Shale DJ.
    Pediatr Pulmonol; 1993 May 21; 15(5):287-91. PubMed ID: 8327287
    [Abstract] [Full Text] [Related]

  • 16. Breath concentration of acetic acid vapour is elevated in patients with cystic fibrosis.
    Smith D, Sovová K, Dryahina K, Doušová T, Dřevínek P, Španěl P.
    J Breath Res; 2016 May 17; 10(2):021002. PubMed ID: 27184114
    [Abstract] [Full Text] [Related]

  • 17. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM.
    JAMA; 2002 Jun 12; 287(22):2958-67. PubMed ID: 12052125
    [Abstract] [Full Text] [Related]

  • 18. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
    Mangiaterra G, Amiri M, Di Cesare A, Pasquaroli S, Manso E, Cirilli N, Citterio B, Vignaroli C, Biavasco F.
    BMC Infect Dis; 2018 Dec 27; 18(1):701. PubMed ID: 30587160
    [Abstract] [Full Text] [Related]

  • 19. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V, Dryahina K, Nunvář J, Sovová K, Elhottová D, Nemec A, Smith D, Španěl P.
    J Breath Res; 2015 Apr 01; 9(2):027104. PubMed ID: 25830686
    [Abstract] [Full Text] [Related]

  • 20. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.
    Enderby B, Smith D, Carroll W, Lenney W.
    Pediatr Pulmonol; 2009 Feb 01; 44(2):142-7. PubMed ID: 19148935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.